Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study

Controlled Clinical Trials

Volumn 17, Issue 4 SUPPL., 1996, Pages

  Wright J T , Jr ^a   Kusek, J W ^a   Toto, R D ^a   Lee, J Y ^a   Agodoa, L Y ^a   Kirk, K A ^a   Randall, O S ^a   Glassock, R ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

AASK Pilot Study; hypertension; kidney disease

Indexed keywords

AMLODIPINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; ENALAPRIL; FUROSEMIDE; HYDRALAZINE; MINOXIDIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHNOLOGY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTICENTER STUDY; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SOCIOECONOMICS; UNITED STATES;

EID: 0029826323     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0197-2456(96)00081-5     Document Type: Article

References (0)